baber/WOPTO huggingface dataset:
Patent EP-1158027-A1 (EP)
Inventor: MURAKAMI HARUJI
IPC: H01R13/03
Filed: 1999-12-10
Abstract: To provide a material improved in dimensional accuracy
and reduced in the extent of deformation caused by warpage
without suffering from a serious reduction in mechanical
properties such as flexural properties, and suitable for
connectors which have a ratio (L/t) of the length (L) of the
product to the average thickness (t) thereof of at least 100
and a ratio (L/h) of the length (L) of the product to the height
(h) thereof of at least 10. A liquid crystal polymer
composition for connectors, having a ratio (L/t) of the length
(L) of the product to the average thickness (t) thereof of
at least 100 and a ratio (L/h) of the length (L) of the product
to the height (h) thereof of not exceeding 10, which is obtained
by blending 100 parts by weight of a liquid crystal polymer
(A) with 5 to 100 parts by weight of a fibrous filler (B) having
an average fiber diameter of 0.5 to 20 µm and an average aspect
ratio of 10 or less and 5 to 100 parts by weight of a particulate
filler (C) having an average particle diameter of 0.1 to 50
µm, the total amount of the fillers not exceeding 150 parts
by weight.
Patent EP-1094512-A1 (EP)
Inventor: FURUTA YOSHIHISA
IPC: C09J183/04
Filed: 1999-12-28
Abstract: A pressure-sensitive adhesive tape (2) is adhered to a
leadframe (1). A semiconductor chip (3) is bonded to the leadframe
(A) having the pressure-sensitive adhesive tape and encapsulated
with a resin in a mold (4). The pressure-sensitive adhesive tape
(2) is stripped after the encapsulating. The resin encapsulating
efficiency is improved, and breakage of bonding parts is prevented
with certainty.
Patent EP-1137526-A1 (EP)
Inventor: GELLERT JOBST ULRICH
IPC: B29C45/73
Filed: 1999-12-07
Abstract: Cette invention a trait à un appareil de moulage par injection dont chaque noyau de moule (10) refroidi, de forme allongé, est pourvu d'une partie interne creuse de forme allongée (78) l'intérieur d'une partie externe creuse de forme allongée (80) et d'une coiffe avant, d'une seule pièce, en forme de dôme (132). La face externe (120) de la partie interne (78) et la face interne (126) de la partie externe (80) comportent des gorges, destinées au transport d'un fluide de refroidissement (122, 128), partant en spirale dans des directions opposées. Cet agencement assure un refroidissement des plus uniforme et force le fluide de refroidissement passant par ces gorges à tourbillonner, ce qui accroît l'efficacité du refroidissement. Cet agencement renforce également la résistance structurale des noyaux de moule (10), ce qui leur permet de supporter des pressions d'injections plus fortes.
Patent EP-1141373-A1 (EP)
Inventor: WOLBERG MICHAEL
IPC: C07B53/00
Filed: 1999-12-08
Abstract: The invention relates to a method for the enantioselective reduction of 3,5-dioxocarboxylic acid derivatives and their syntheses. According to the invention, compounds of formula (4) are reacted with an alcohol dehydrogenase which preferably stems from Lactobacillus brevis and which is recombinantly over-expressed in Escherichia coli, in the presence of NADPH. The keto group in position 5 is enantioselectively reduced during this reaction. The keto group in position 3 can also be specifically syn- or anti-reduced in a further step by means of chemical or enzymatic reactions.
Patent EP-1140072-A1 (EP)
Inventor: BONDINELL WILLIAM E
IPC: A61K31/167
Filed: 1999-12-28
Abstract: This invention relates to substituted benzanilides which are modulators, agonists or antagonists, of the CCR5 receptor. In addition, this invention relates to the treatment and prevention of disease states mediated by CCR5, including, but not limited to, asthma and atopic disorders (for example, atopic dermatitis and allergies), rheumatoid arthritis, sarcoidosis and other fibrotic diseases, atherosclerosis, psoriasis, autoimmune diseases such as multiple sclerosis, and inflammatory bowel disease, all in mammals, by the use of substituted benzanilides which are CCR5 receptor antagonists. Furthermore, since CD8+ T cells have been implicated in COPD, CCR5 may play a role in their recruitment and therefore antagonists to CCR5 could provide potential therapeutic in the treatment of COPD. Also, since CCR5 is a co-receptor for the entry of HIV into cells, selective receptor modulators may be useful in the treatment of HIV infection.
Patent EP-1135297-A1 (EP)
Inventor: FRANZEN BJOERN
IPC: B65D1/20
Filed: 1999-11-05
Abstract: A container has a chamber (10) for liquid, a pouring opening (30) in the upper part of the chamber and having an essentially vertical longitudinal axis, and a handle (20) arranged above the chamber. In the handle there is an air duct (22), which at a first end emerges in the chamber and at a second end emerges in the pouring opening. In the pouring opening, a wall (34) is placed between a part (36) for liquid which is connected to the chamber and a part (38) for air in which the second end of the air duct emerges. An opening (40) is arranged in the wall between the part for liquid and the part for air. This opening ensures better manufacturing quality and ventilation when the container is emptied.
Patent FI-20177099-A1 (FI)
Inventor: PIIROINEN JUKKA-PEKKA
IPC: B60Q1/50
Filed: 2017-09-04
Abstract: Uppfinningen tillhör klassen transport, arrangemang av signaleringsanordningar hos fordon. Fordonets körriktningsvisare har placerats i vindrutans övre parti eller i A-pelaren (11), där körriktningsvisaren riktas mot fordonets mittlinje betraktat (21) från färdriktningen. Vindrutakörriktningsvisaren har placerats på fordonet på fotgängarnas/cyklisternas och andra fordons ögonnivå betraktat (51) från horisontallinjen av körriktningsvisarens Ijusstråle. Körriktningsvisaren syns och fungerar enligt E 48-regeln i Europa. Målet med uppfinningen är att förbättra trafiksäkerheten för fotgängare och cyklister när fordon kör ut ur rondeller. När man ser (31) fordonets svängriktning tidigare, förbättrar det trafikflödet och dess förutsägbarhet och minskar risken för krockar mellan fotgängare/cyklister och fordon. När man ser körriktningsvisaren tidigare, ger det också tid att reagera och sänka sin hastighet och observera om fordonsföraren har lagt märke till eventuell korsande trafik. Uppfinningen gör också att fordon kan köra in i rondeller smidigare och på ett miljövänligare sätt, eftersom de kan undvika att stanna i onödan i och med att de tidigare kan se körriktningsvisaren av fordon som kör ut ur ondellen.
Patent HK-1025363-A1 (HK)
Title: Process for treating a material containing metal and organic matter, including metal separation
Inventor: NIEMINEN MATTI
IPC: C22B1/00
Filed: 2000-07-24
Abstract: A process for treating a raw material containing aluminum or a similar metal melting at a low temperature and organic matter, including metal separation, particularly intended for the treatment of liquid container rejects consisting of aluminum foil, polymer material and possible fibre residues in order to recover the aluminum and to utilise the organic matter as a fuel. The raw material is introduced in a bubbling fluidised bed, where the organic matter is gasified at a temperature higher than the melting point of the metal present. The gas removed from the fluidised bed and the entrained metal are subsequently cooled to a temperature below the melting point of metal by admixing a cooling medium such as water in the gas flow. The solid metal particles are eventually separated from the gas e.g. with a cyclone and the gas flow is possibly filtered before combustion.
Patent HK-1029152-A1 (HK)
Title: Paving of concrete paving stones
Inventor: GEIGER PETER
IPC: E01C/
Filed: 2000-10-05
Abstract: The paving stone laying system (1) consists of several immediately adjacently arranged laying packages of concrete paving stones (2). Each laying package consists of a number of parallel rows of paving stones of the same length and the same or different lengths in each row.
Patent HK-1027842-A1 (HK)
Title: Composite yarn with fiberglass core
Inventor: KOLMES NATHANIEL H
IPC: D02G3/36
Filed: 2000-10-30
Abstract: The present invention relates to a yarn core construction suitable for forming a flexible composite yarn having a fiberglass component. The resulting yarn has good cut and abrasion resistance qualities without sacrificing knittability, flexibility and suppleness. A normally hard to knit fiberglass strand is wrapped with a sheath strand at a rate of at least 8 turns per inch. The core thus formed provides all of the benefits of a fiberglass supported yarn without experiencing any of the manufacturing difficulties normally associated with fiberglass yarns. The core may also be provided with a multi-layer covering to balance the yarn and to further improve knittability.
Patent HK-1029986-A1 (HK)
Title: Process for preparing malonic esters.
Inventor: HILDBRAND STEFAN
IPC: B01J31/02
Filed: 2001-02-08
Abstract: Malonic esters of the general formulawhere R is C1-10-alkyl, C3-10-alkenyl or aryl-C1-4-alkyl, are prepared by reacting an alkali metal salt of malonic acid with a halide of the general formula R-X (II), where R is as defined above and X is chlorine, bromine or iodine, in the presence of water and a phase-transfer catalyst.
Patent HK-1040636-A1 (HK)
Title: Therapeutic agent for the suppression of snoring noises
Inventor: BIGALKE HANS
IPC: A61P11/00
Filed: 2002-03-28
Abstract: In a method of manufacturing a therapeutic agent to be administered intramuscularly for suppressing snoring noises a high-purity Clostridium toxin BoNT/A or TeNT or at least one of a high-purity Clostridium toxin BoNT/B, BoNT/C1, BoNT/D, BoNT/E, BoNT/F and BoNT/G is added to a carrier. In an alternative, one or more hybrid proteins as a Clostridium toxin, having a light subunit of a Clostridium toxin of the following group and a heavy subunit of a different Clostridium toxin of the same following group, which group contains BoNT/A, BoNT/B, BoNT/C1, BoNT/D, BoNT/E, BoNT/F, BoNT/G and TeNT, are added to a carrier. According to another alternative, a complex, containing a Clostridium toxin or a hybrid protein, and further containing one or more therapeutically well-tolerated hemagglutinins and/or pharmaceutically well-tolerated non-toxic proteins, is added to a carrier. The carrier can be an aqueous solution, a saline solution, or liposomes.
Patent HK-1083634-A1 (HK)
Title: Nematic liquid crystal mixtures for bistable display devices
Inventor: MARTINOT-LAGARDE PHILIPPE
IPC: C09K19/44
Filed: 2006-05-18
Abstract: Mixtures of nematic crystals for bistable displays with a low energy of anchorage. Nematic liquid crystal mixtures for bistable displays comprises: (a) at least 40 % wt. of compounds of high molecular polarisability(delta e greater than 10) and high dipole moment(psi greater than 1 D) but with a low zenithal anchorage of formulae (AI) - (AIV); (b) 0 - 60 % of compounds of low anchorage of formulae (BI), (BII), (EI), (EII), (FI) and (FII); (c) 0 - 25 % of compounds comprising dipoles, from compounds of formulae (CI) and (CII); (d) 0 - 10 % of a compound of formula (D); (a) [Image] R 1-CN, -NCS, -F or -CF 3; R 2R- or RCOO- (R is 1 - 12C alkyl); R 3R- or RCOO- (R = 1 - 12C alkyl or cycloaliphatic); Z 1, Z 2(identical or different) : -CC-, -CH 2CH 2-, -COO- -OOOC- or single bonds; X 1, X 2(identical or different) : F, Cl or H. [Image] R 4, R 5(identical or different) : R- or RCOO- (R is 1 - 12C alkyl or alkoxy, or 3 - 8C cycloaliphatic ); Z 1, Z 2(identical or different) : -CC-, -CH 2CH 2-, -COO-, -OOC- or sinlge bonds; X 1, X 2F, Cl or H; X 3, X 4H or Hal, or R- or RO- (R is 1 - 12C alkyl). [Image] [Image] R 1-CN, -NCS, -F or -CF 3; R 2R- or RCOO-(R = 1 - 12C). Z 1, Z 2(identical or different) : -CC-, -CH 2CH 2-. -COO-, -OOC- or single bonds; X-1, X 2(identical or different) : F, Cl or H. The mixtures have the following physical characteristics :- Nematic transition temperature-liquid isotrope (TN-1) greater or equal to +50 [deg] C ; Nematic level delta TN greater or equal to 50 [deg] C ; Positive dielectric anisotropy greater or equal to 8(20 [deg] C) ; Low zenithal anchorage on at least one of the plates of the bistable display(characterized by a breakdown voltage, Ulambda /2 less than 25 volts, for a cell of thickness d such that ddelta n = 295 nm). Independent claims are also included for the bistable display apparatus comprising the liquid crystal mixture and use.
Patent HK-1096088-A1 (HK)
Title: Platelet adp receptor inhibitors
Inventor: SCARBOROUGH ROBERT M
IPC: A61K31/16
Filed: 2004-09-10
Abstract: Novel compounds of formulae (I), which more particularly include sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives which are effective platelet ADP receptor inhibitors. These derivatives may be used in various pharmaceutical compositions, and are particularly effective for the prevention and/or treatment of cardiovascular diseases, particularly those diseases related to thrombosis. The invention also relates to the use of an effective amount of a compound of formulae (I), or a pharmaceutically acceptable salt thereof, in the manufacture of a pharmaceutical composition for preventing or treating thrombosis in a mammal.
Patent HK-1100877-A1 (HK)
Title: N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them
Inventor: BOMBARDELLI EZIO
IPC: C07C323/41
Filed: 2007-08-08
Abstract: Disclosed is a series of N-deacetylthiocolchicine derivatives of formula I in which: the linker is a bivalent straight or branched C1-C8 alkyl residue, C3-C8 cycloalkyl, a phenylene or heterocyclic C4-C6 ring; the G1 and G2 junctions, which can be the same or different, are —CO—, —CONH—, —CR2— groups in which R2 is hydrogen or a straight C1-C4 alkyl residue, or the G1-linker-G2 group is the —CO— group. The compounds of formula I have antiproliferative, antinflammatory, antiarthritic and antiviral activity.
Patent HK-1103391-A1 (HK)
Title: Cationic lipids and methods of use
Inventor: MACLACHLAN IAN
IPC: A61K/
Filed: 2007-10-30
Abstract: The present invention provides compositions comprising cationic lipids, liposomes and nucleic acid-lipid particles comprising the cationic lipids, and methods of using such compositions, liposomes, and nucleic acid-lipid particles.
Patent HK-1110833-A1 (HK)
Title: Barbed sutures
Inventor: LEUNG JEFFREY C
IPC: A61B17/04
Filed: 2008-05-14
Abstract: This invention relates to an unidirectional barbed suture for connecting human or animal tissue, said suture comprising an elongated body having a longitudinal axis, a cross-sectional distance or diameter (SD), a first end and a second end, where a needle having a needle diameter (ND) is attached to the first end and a needle is not attached to the second end; and a plurality of barbs projecting from the body towards the second end; wherein the barbs are staggered along the body in three sets with 120 degree spacing between any two sets; and a plurality of barbs comprising a configuration wherein a ratio of a barb cut depth (D) to the cross-sectional distance or diameter (SD) is about 0.05 to about 0.6.
Patent HK-1114054-A1 (HK)
Title: Component comprising a derived timber product, mounting stuck thereto, and method for producing said component
Inventor: RIEPERTINGER MANFRED
IPC: B27M/
Filed: 2008-09-03
Abstract: The invention relates to a method for fixing a mounting (12) to a derived timber product (4). According to said method: the contact area of the mounting is at least partially provided with an adhesive; the contact area of the mounting is then brought into contact with the derived timber product; the adhesive is inductively heated and activated by means of magnetic induction, and; an adhesive connection is created by the hardening adhesive, between the mounting and the derived timber product. The invention also relates to a component produced according to said method.
Patent HK-1114634-A1 (HK)
Title: Il-17 homologous polypeptides and therapeutic uses thereof
Inventor: CHEN JIAN
IPC: C12N15/12
Filed: 2008-09-10
Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
Patent HK-1123193-A1 (HK)
Title: Argatroban formulation comprising an acid as solubilizer
Inventor: OWOO GEORGE
IPC: A61K/
Filed: 2009-01-19
Abstract: An aqueous, stable, sterile pharmaceutical composition of the thrombin inhibitor argatroban in a solution containing an acid to solubilize the argatroban, substantially free from dehydrated alcohol is described, as well as a method for its preparation.
Patent HK-1121886-A1 (HK)
Title: Data communication protocol
Inventor: MOHAMED AHMED
IPC: H04L/
Filed: 2007-05-29
Abstract: Described are sequence numbers for client-server communication, to control a client's use of server resources. A server grants the client credits, and the client consumes a credit for sending each command to the server. Each credit corresponds to a sequence number, with the set of sequence numbers forming a valid command window. The server enforces that for each received command, the command includes a sequence number that is within the valid command window and that the sequence number has not been used with another command. The server may also maintain a maximum window size, such that clients with credits cannot send a command with a sequence number that beyond a maximum sequence number. When incorporated into a data communication protocol, quality of service, combating denial of service, detection of message loss, division of server resources, secure message signing, and other numerous benefits result.
Patent HK-1126488-A1 (HK)
Title: Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
Inventor: GOMTSYAN ARTHUR
IPC: A61P13/10
Filed: 2006-11-14
Abstract: The present invention discloses novel compounds of general formula (I), or a pharmaceutically acceptable salt thereof (in which X 1  - X 5 , R 5  - R 8b , Z 1  - Z 2  and Ar 1  are defined herein), pharmaceutical compositions including those compounds and a process for making those compounds. The compounds of formula (I) are useful for treating pain, bladder overreactivity, urinary incontinence, inflammatory hyperalgesia by inhibiting the VR1 receptor in mammals.
Patent HK-1141705-A1 (HK)
Title: Sucking device for drinking purposes
Inventor: ITZEK ECKHARD
IPC: A61J/
Filed: 2010-09-02
Abstract: A bottle teat made of a soft elastic material, comprising: a hollow suction nipple, a circumferential mounting edge for fixation to the bottle opening of a drinking bottle, a hollow transition zone between the mounting edge and the suction nipple, and two drinking slots extending from the outer side to the inner side of the suction nipple in an end region of the suction nipple, which are aligned in parallel to each other and whose distance from each other decreases from the outer side towards the inner side of the suction nipple.
Patent HK-1142164-A1 (HK)
Title: Systems and methods for maintaining data integrity of removable media of an electronic device
Inventor: WOOD ROBERT
IPC: G11C/
Filed: 2010-09-03
Abstract: The described embodiments relate generally to methods, systems and devices for maintaining data integrity of a removable storage media of an electronic device, particularly when such storage media is removed from such device.
Patent HK-1145893-A1 (HK)
Title: Executable download tracking system
Inventor: GRAY ROBERT J
IPC: G06F/
Filed: 2011-01-05
Abstract: Systems and methods are disclosed for monitoring executable software applications on a computer network. Executable software applications and data files may be monitored by a risk monitoring system. The executable software application and data files may attempt to access a computer network and/or a computing device and a monitoring process may identify risks associated with the executable software application and/or data file. A suspicious characteristic of the executable software application may be identified during the monitoring process. The suspicious characteristic may be malware and may be neutralized before it causes damage to the computer network and/or computing device.
Patent HK-1000449-A1 (HK)
Title: Tissue plasminogen activator glycosylation variants with improved therapeutic properties
Inventor: BENNETT WILLIAM F
IPC: A61K38/46
Filed: 1997-09-23
Abstract: The invention concerns tissue plasminogen activator (t-PA) variants which are glycosylated at any of positions 103-105, and are devoid of functional carbohydrate structure at position 117 of wild-type human t-PA amino acid sequence. The variants have extended circulatory half-life and substantially retained fibrin binding, or improved in vivo fibrinolytic potency, as compared to wild-type human t-PA. <IMAGE>
Patent HK-1005893-A1 (HK)
Title: Human gamma delta t cell antigen receptor polypeptides and nucleic acids
Inventor: BRENNER MICHAEL B
IPC: G01N33/569
Filed: 1998-06-06
Abstract: The present invention provides purified polypeptides which comprise at least a portion of a  delta  T cell receptor polypeptide, a  gamma T cell receptor polypeptide, a  gamma ,  gamma  T cell receptor complex or a  gamma ,  delta  T cell receptor complex. Substances capable of forming complexes with these polypeptides are also provided. Additionally, methods for detecting T cells which have within them or on their surfaces a polypeptide of the present invention are provided. Moreover, methods for diagnosing immune system abnormalities are provided which comprise measuring in a sample from a subject the number of T cells which have within them or on their surfaces a polypeptide of the present invention.
Patent HK-1006155-A1 (HK)
Title: Transdermal acrylic multipolymer drug delivery system
Inventor: SABLOTSKY STEVEN
IPC: B26F1/44
Filed: 1998-06-12
Abstract: A dermal composition comprising a drug, a multipolymer of ethylene-vinyl acetate, an acrylic polymer, and optionally one or more monomers, a natural or synthetic rubber and a tackifying agent. The ratio of the multipolymer to the rubber is, respectively, about 1:1 to about 10:1 and more preferably, 1:1 to 5:1 and more preferably 3:1. The dermal composition can optionally contain a cross linking agent, tackifiers, penetration enhancers and other ingredients known for use in adhesives for the transdermal delivery of drugs. The dermal compositions can be produced by a variety of methods known in the preparation of drug containing adhesive preparations including the homogenous mixing of the multipolymer, drug and optional crosslinking agent and additional ingredients in solution or suspension or emulsion followed by removal of excess solvent.
Patent HK-1008657-A1 (HK)
Title: Copolymer-1 improvements in compositions of copolymers
Inventor: KONFINO ELIEZER
IPC: A01N37/18
Filed: 1998-07-02
Abstract: The present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons.
Patent IE-20010862-A1 (IE)
Title: Indole derivatives as 5-HT1 like agonists
Inventor: MARTIN GRAEME RICHARD
IPC: A61K31/40
Filed: 1991-06-06
Abstract: The present invention relates to indole derivatives as 5HT1-likes agonists and their preparation.  The invention also relates to pharmaceutical formulations containing the indole derivatives, their use in medicine and particularly the prophylaxis and treatment of migraine.